Ninety patients were randomized to receive either intermittent midazolam boluses ( @-@ mg ) with @-@ @ g/kg/h of remifentanil ( MR group ) or dexmedetomidine @-@ @ g/kg/h after a loading dose of @ g/kg with @-@ @ g/kg/h of remifentanil ( DR group ) .